Cargando…
MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
BACKGROUND: Approximately 10% of Lynch syndrome families have a mutation in MSH6 and fewer families have a mutation in PMS2. It is assumed that the cancer incidence is the same in families with mutations in MSH6 as in families with mutations in MLH1/MSH2 but that the disease tends to occur later in...
Autores principales: | Talseth-Palmer, Bente A, McPhillips, Mary, Groombridge, Claire, Spigelman, Allan, Scott, Rodney J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890527/ https://www.ncbi.nlm.nih.gov/pubmed/20487569 http://dx.doi.org/10.1186/1897-4287-8-5 |
Ejemplares similares
-
Lynch syndrome mutation spectrum in New South Wales, Australia, including 55 novel mutations
por: Sjursen, Wenche, et al.
Publicado: (2016) -
Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts
por: Talseth-Palmer, Bente A, et al.
Publicado: (2012) -
Targeted next‐generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families
por: Talseth‐Palmer, Bente A., et al.
Publicado: (2016) -
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2
por: Haraldsdottir, Sigurdis, et al.
Publicado: (2017) -
MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer
por: Roberts, Maegan E, et al.
Publicado: (2018)